These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18348351)

  • 1. Accuracy of US cancer surveillance under threat.
    Furlow B
    Lancet Oncol; 2007 Sep; 8(9):762-3. PubMed ID: 18348351
    [No Abstract]   [Full Text] [Related]  

  • 2. Unreported VA data may affect SEER research, cancer surveillance, and statistics gathering.
    Savage L
    J Natl Cancer Inst; 2007 Dec; 99(23):1744-5, 1752. PubMed ID: 18042924
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of National Program of Cancer Registries SAS Tool for Population-Based Cancer Relative Survival Analysis.
    Dong X; Zhang K; Ren Y; Wilson R; O'Neil ME
    J Registry Manag; 2016; 43(2):63-73. PubMed ID: 27556840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building the infrastructure for nationwide cancer surveillance and control--a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States).
    Wingo PA; Jamison PM; Hiatt RA; Weir HK; Gargiullo PM; Hutton M; Lee NC; Hall HI
    Cancer Causes Control; 2003 Mar; 14(2):175-93. PubMed ID: 12749723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma surveillance in the United States: overview of methods.
    Watson M; Johnson CJ; Chen VW; Thomas CC; Weir HK; Sherman R; Cockburn M; Jackson-Thompson J; Saraiya M
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S6-16. PubMed ID: 22018069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and determinants of missing data in clinical and prognostic variables recently added to SEER.
    Kim HM; Goodman M; Kim BI; Ward KC
    J Registry Manag; 2011; 38(3):120-31. PubMed ID: 22223054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?
    Merrill RM; Dearden KA
    Cancer Causes Control; 2004 Dec; 15(10):1027-34. PubMed ID: 15801487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Institutional commitment to rectal cancer screening results in earlier-stage cancers on diagnosis.
    Battat AC; Rouse RV; Dempsey L; Safadi BY; Wren SM
    Ann Surg Oncol; 2004 Nov; 11(11):970-6. PubMed ID: 15525825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The National Program of Cancer Registries: explaining state variations in average cost per case reported.
    Weir HK; Berg GD; Mansley EC; Belloni KA
    Prev Chronic Dis; 2005 Jul; 2(3):A10. PubMed ID: 15963312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation in research and social context: the case of population-based cancer registration, surveillance, and research.
    McLaughlin RH
    Am J Bioeth; 2008 Oct; 8(10):41-2. PubMed ID: 19003707
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of the California tobacco control program with declines in lung cancer incidence.
    Barnoya J; Glantz S
    Cancer Causes Control; 2004 Sep; 15(7):689-95. PubMed ID: 15280627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hawaii Tumor Registry: more than forty years of cancer surveillance for the islands.
    Hernandez BY
    Hawaii Med J; 2002 Mar; 61(3):53. PubMed ID: 11965840
    [No Abstract]   [Full Text] [Related]  

  • 13. Examination of Preliminary Cancer Surveillance Data from the National Program of Cancer Registries, Diagnosis Year 2012.
    Freeman MBB; Wilson RJ; Ryerson B
    J Registry Manag; 2017; 44(2):62-8. PubMed ID: 29611676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US Department of Veterans Affairs medical care system as a resource to epidemiologists.
    Boyko EJ; Koepsell TD; Gaziano JM; Horner RD; Feussner JR
    Am J Epidemiol; 2000 Feb; 151(3):307-14. PubMed ID: 10670556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatives to a national system of population-based state cancer registries.
    Thomas DB
    Am J Public Health; 2002 Jul; 92(7):1064-6. PubMed ID: 12084679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing clinical data: a cancer registries update.
    Watkins S
    J AHIMA; 1997; 68(7):22-5. PubMed ID: 10168978
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer registries in epidemiologic research.
    Storm HH
    Cancer Causes Control; 1996 May; 7(3):299-301. PubMed ID: 8734821
    [No Abstract]   [Full Text] [Related]  

  • 19. Case-Completeness of Nonmalignant Central Nervous System Tumors in the Canadian Cancer Registry, 2011-2015.
    Zakaria D; Shaw A; Woods R; De P; Davis F
    J Registry Manag; 2018; 45(1):117-131. PubMed ID: 31017881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent improvement in completeness of incidence data on acute myeloid leukemia in US cancer registries.
    Polednak AP
    J Registry Manag; 2014; 41(2):77-84. PubMed ID: 25153013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.